ARCHIVES

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

This article is from The Cancer Letter archive.

Vol. 19 No. 20 | May 14, 1993

Download PDF Visit The Full Archive

Related Articles

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

HCFA Sees Applications For DRGs And Research

September 27, 1985

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money

February 1, 1985